Innovating Works

EVERSENS

Activa
PTQ2020-011476: OXINER. ÓXIDO NÍTRICO EXHALADO PARA SU APLICACIÓN EN ENFERMEDADES RESPIRATORIAS EVERSENS tramitó un AEI: 2020-01-01 | Financiado
NOA: NOA, a disruptive portable device to monitor asthma EVERSENS tramitó un H2020: In Europe, about 30 million children and adults under 45 years old have asthma. There is no cure for asthma, it is a chronic disease. Asthma can have a very negative impact on the quality of life of t...
2017-06-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.